Adjuvant Nivolumab Beneficial in Esophageal, GE Junction Cancer
A study found that patients with gastroesophageal junction cancer who were treated with surgery and chemoradiotherapy had significantly longer disease-free survival if... Read More
Adjuvant chemotherapy is superior to chemoradiation after D2 surgery for gastric cancer
Chemotherapy after surgery for gastric cancer was superior to chemoradiation in a recent trial.
Survival Outcomes of Gastric and Gastroesophageal Junction Adenocarcinomas Treated With Perioperative Chemotherapy ± Preoperative Radiotherapy
A new study of patients with early- and mid-stage gastric cancer found that those treated with chemo and radiation before surgery were... Read More
Adjuvant Chemotherapy or Adjuvant Chemoradiotherapy for Gastric Cancer?—A West Cancer Center Perspective
“If you gave everybody neoadjuvant chemotherapy, is there an added benefit for chemoradiation after surgery?” Watch researchers from West Cancer Center explain... Read More
Potentially curable gastric adenocarcinoma treated without surgery
A new study in the European Journal of Cancer finds combination chemoradiation therapy should be the preferred treatment option for localized gastric... Read More
Added radiotherapy does not improve gastric cancer survival
New findings from an international clinical trial: postoperative chemoradiotherapy after gastric cancer surgery does not improve overall survival, compared with postoperative chemotherapy... Read More
